Drawing for Y

USPTO serial 86675925

Y

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KUNKLEMAN, SARAH E
Law office
TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Y?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anthony L. Goodman

ANTHONY L. GOODMAN Altman Schochet Llp225 Broadway Fl 39New York, NY 10007-3001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Amino acids for laboratory or research use; Assays and reagents for use in genetic research; Assays for research purposes; Bacterial preparations other than for medical and veterinary use; Biochemical reagents used for non-medical purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biochemicals, namely, polypeptides for in vitro research use; Biological indicators for monitoring sterilization processes other than for medical or veterinary purposes; Biological preparation for use in cell cultures other than for medical or veterinary use; Biological tissue cultures other than for medical or veterinary purposes; Biological tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Biological tissue, namely, SHED stem cells (stem cells from human exfoliated deciduous teeth), dental pulp and human maxiofacial bone elements for scientific use and research in cellular healing therapies; Biological tissue, namely, human tissue for use in scientific and medical research; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Cell culture media for scientific and research use; Cell culture reagents for scientific and research use; Cell growth media for growing cells for scientific and research use; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Chemical preparations, namely, silica based density centrifugation media, to be used in biochemical and clinical research; Chemical reagents for non-medical purposes; Chemical reagents for non-medical purposes, namely, for use in evaluating human performance; Chemical reagents, other than for medical or veterinary purpose; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Chemical test kits for medical and health evaluations for laboratory or research use; Chemically activated adhesive label for sensing the presence of oxygen in intravenous medical and pharmaceutical containers; Chemically treated non-medical test strips for calibration of laboratory test equipment; Cryopreservation kits for use in scientific research consisting primarily of sperm freezing medium, in vitro fertilization medium, sperm freezing canister, cans for holding straws filled with semen, and mixing tubes; Cultures of microorganisms other than for medical and veterinary use; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific or research use; Electrophoresis gels other than for medical or veterinary purposes; Enzymes for scientific and research purposes; Fluorescent dye for scientific or research use; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Medical grade polyurethanes for use in the manufacture of medical tubing, films, sprays, and membranes; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Nucleotides for scientific and research use; Pheromones, not for medical use; Photosensitive paper for use in medical imagery; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Protein arrays and nucleotide arrays for scientific and medical research; Protein in raw material form for scientific and medical research; Reagent paper other than for medical purposes; Reagents for research purposes; Reagents for scientific and research use; Reagents for scientific or medical research use; Reagents for testing the sterility of medical equipment; Research reagents for industrial use, namely, for food testing; Seed coating applied to corn, soybeans, wheat and alfalfa seeds to improve stands, seedling health and yield; Specialty chemicals, namely, chemical additives for use in the manufacture of fabrics and of surfaces of a wide variety of manufactured products, for health and safety related purposes; Stem cells for research or scientific purposes; Stem cells for research purposes; Stem cells other than for medical or veterinary purposes; Tanning agents for use in the manufacture of leather, namely, oils for preparing leather in the course of manufacture; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 10, 2016MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 10, 2016ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 13, 2015GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 13, 2015GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 13, 2015CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 5, 2015DOCKASSIGNED TO EXAMINER—
Jul 7, 2015MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 4, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 30, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance